Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
10,954,007
-
Shares change
-
+315,676
-
Total reported value, excl. options
-
$139,545,784
-
Value change
-
+$4,079,335
-
Number of buys
-
30
-
Number of sells
-
-18
-
Price
-
$12.74
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2016
60 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2016.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,954,007 shares
of 55,482,166 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include FMR LLC (3,973,851 shares), Bain Capital Public Equity Management, LLC (1,514,082 shares), Partner Fund Management, L.P. (1,384,151 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (446,080 shares), BlackRock Fund Advisors (385,055 shares), Casdin Capital, LLC (385,000 shares), VANGUARD GROUP INC (382,124 shares), GOLDMAN SACHS GROUP INC (307,095 shares), EVENTIDE ASSET MANAGEMENT, LLC (300,000 shares), and DEERFIELD MANAGEMENT CO (235,294 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.